The alternatives
GOAL.MD scores 73/100 (grade C, ranked #104) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.
Published by The GLP-1 Verdict
Check dates vary by provider.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to GOAL.MD's 73, and our GOAL.MD vs CoreAge Rx comparison sets the two out factor by factor.
Corsica Health is a telehealth platform offering both compounded GLP-1s and brand-name FDA-approved injections through a structured assessment, provider review, and medication flow.
Corsica Health matches GOAL.MD at 73/100; our full write-up on Corsica Health has the pricing conditions and the caveats in detail.
DTC telehealth weight-loss program (Nexus Health Solutions LLC) offering flat-rate compounded semaglutide and tirzepatide, with the consultation, prescription, medication, and shipping bundled into one…
Harper Meds matches GOAL.MD at 73/100; the full Harper Meds review has the pricing conditions and the caveats in detail.
Telehealth weight loss provider selling a compounded GLP-1 injection at one price at every dose.
Amble matches GOAL.MD at 73/100; the full Amble review has the pricing conditions and the caveats in detail.
Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.
Ivy Rx matches GOAL.MD at 73/100; the full Ivy Rx review has the pricing conditions and the caveats in detail.
Direct-to-consumer telehealth provider offering among the lowest we track compounded GLP-1 pricing of the programs we track.
AmberHealth matches GOAL.MD at 73/100; our full write-up on AmberHealth has the pricing conditions and the caveats in detail.
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.
Kina matches GOAL.MD at 73/100; our Kina review in full has the pricing conditions and the caveats in detail.
See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.